COPD - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic inflammation leads to structural changes in the lungs, causing airway narrowing and destruction of alveolar walls. This results in airflow limitation and impaired gas exchange.

• Secondary mechanism: Mucus hypersecretion due to goblet cell hyperplasia and submucosal gland hypertrophy further obstructs airways, exacerbating airflow limitation and increasing the risk of lung infections.

• Key complication: Persistent airflow limitation and gas trapping lead to hyperinflation, reducing lung elasticity and causing increased work of breathing, ultimately contributing to respiratory failure.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Chronic obstructive pulmonary disease (diagnosed 5 years ago), hypertension, type 2 diabetes

• Current medications: Tiotropium, Salbutamol, Lisinopril, Metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath and productive cough

• Key symptoms: Wheezing, fatigue, mild cyanosis, occasional chest tightness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 98 bpm, respiratory rate 24 breaths per minute, SpO2 88% on room air, temperature 37.2°C

Section 1

As the healthcare team continues to monitor the patient, new diagnostic results provide additional insights into his condition. A recent chest X-ray reveals hyperinflation of the lungs and evidence of increased bronchial wall thickening, indicative of chronic bronchitis. Additionally, a sputum culture returns positive for Haemophilus influenzae, suggesting a bacterial infection that may be contributing to the patient's increased cough and sputum production. Laboratory tests show an elevated white blood cell count of 12,500 cells/mcL, indicating an inflammatory response, while arterial blood gas analysis demonstrates a pH of 7.34, PaCO2 of 52 mmHg, and PaO2 of 55 mmHg, confirming respiratory acidosis with hypoxemia.

These findings suggest that the patient is experiencing an exacerbation of COPD, complicated by a bacterial infection, which is contributing to his worsening respiratory status. The team decides to initiate antibiotic therapy with azithromycin, given the patient's penicillin allergy, and adjust his bronchodilator regimen to include more frequent doses of Salbutamol. Additionally, supplemental oxygen is provided to maintain SpO2 levels above 92%, recognizing the need to balance oxygenation with the risk of worsening CO2 retention.

The clinical reasoning process involves considering the impact of the infection on the patient's already compromised respiratory system, recognizing the potential for further deterioration if the infection is not effectively managed. The healthcare team must monitor the patient's response to the interventions closely, watching for signs of improvement or any new complications, such as respiratory failure or cardiac stress, given his underlying conditions. This stage of his care highlights the importance of timely intervention and vigilant monitoring to prevent further escalation of his condition.

Section 2

As the healthcare team continues to administer the prescribed interventions, they observe a change in the patient's status that warrants immediate attention. Over the past 12 hours, the patient, Mr. Johnson, has developed increased dyspnea and reports feeling more fatigued despite the supplemental oxygen therapy. His respiratory rate has climbed to 28 breaths per minute, and auscultation reveals louder wheezes and diffuse crackles throughout both lung fields, suggesting worsening bronchospasm and fluid buildup. His SpO2 remains fluctuating around 88-90%, indicating a struggle to maintain adequate oxygenation even with the adjusted bronchodilator regimen and supplemental oxygen. These findings suggest that the current management may not be sufficient to address the exacerbation and underlying infection.

In response to these changes, the healthcare team decides to order a repeat arterial blood gas analysis and additional lab tests to better understand the current physiological state. The new ABG results show a pH of 7.30, PaCO2 of 58 mmHg, and PaO2 of 50 mmHg, indicating worsening respiratory acidosis and hypoxemia. Additionally, the patient's heart rate has increased to 112 beats per minute, and his blood pressure has dropped to 95/60 mmHg, raising concerns about potential hemodynamic instability. Given these developments, the team suspects that Mr. Johnson may be experiencing early signs of respiratory failure and possibly sepsis secondary to the bacterial infection.

The team acknowledges the need for intensified intervention, considering the possible escalation to non-invasive ventilation support to assist with respiratory effort and further antibiotic coverage targeting Haemophilus influenzae. They also consider consulting with the pulmonology and infectious disease specialists to explore alternative management strategies. The evolving clinical picture underscores the necessity for continued vigilance and adaptability in the treatment plan to stabilize Mr. Johnson and prevent further deterioration.

Section 3

Following the decision to implement non-invasive ventilation (NIV) and broaden antibiotic therapy, Mr. Johnson's clinical status is closely monitored for any signs of improvement or further complications. The application of NIV, set at appropriate pressure settings, aims to reduce the work of breathing and improve gas exchange. Initially, Mr. Johnson exhibits a modest response, with a slight decrease in respiratory rate to 24 breaths per minute and a marginal improvement in SpO2, now fluctuating between 90-92%. However, the team remains concerned about his hemodynamic status, as his blood pressure continues to trend low at 92/58 mmHg, and his heart rate remains elevated at 110 beats per minute.

Lab results return, showing an elevated white blood cell count of 15,000 cells/µL, corroborating the suspicion of an active infectious process. Blood cultures are pending, but the preliminary findings of the sputum culture suggest the presence of Haemophilus influenzae, affirming the choice of targeted antibiotic therapy. Despite these interventions, Mr. Johnson exhibits signs of increasing agitation and confusion, indicative of worsening hypoxemia and potential hypercapnia. These neurological changes prompt the team to reassess his neurological status frequently and consider the need for further respiratory support escalation.

With the current trajectory, the healthcare team considers a transfer to the intensive care unit for closer monitoring and potential mechanical ventilation if Mr. Johnson's respiratory status continues to decline. Pulmonology and infectious disease specialists are actively engaged in discussions to refine the management plan, focusing on optimizing ventilation settings and reviewing the efficacy of the antibiotic regimen. The evolving scenario underscores the complexity of Mr. Johnson's condition, demanding a dynamic and multidisciplinary approach to prevent progression to full respiratory failure and septic shock. The team's ongoing challenge is to stabilize Mr. Johnson while minimizing the risk of further complications.

Section 4

As Mr. Johnson is transferred to the intensive care unit, the healthcare team conducts an initial assessment to establish a comprehensive baseline of his current status. Despite the earlier interventions, his respiratory rate has increased to 30 breaths per minute, and his SpO2 has dropped to 88%, even with the NIV support. His heart rate remains elevated at 115 beats per minute, and his blood pressure is now critically low at 88/54 mmHg. Neurologically, Mr. Johnson's agitation has escalated to a level of altered consciousness, with a Glasgow Coma Scale score of 13, indicating a drop in responsiveness and increased lethargy.

New arterial blood gas results reveal a pH of 7.28, PaCO2 of 60 mmHg, and PaO2 of 55 mmHg, confirming significant respiratory acidosis and hypoxemia, contributing to his altered mental status. Additionally, a repeat complete blood count indicates a further rise in his white blood cell count to 17,500 cells/µL, suggesting a persistent and potentially worsening infection. Lactate levels are elevated at 3.2 mmol/L, raising concerns about developing tissue hypoperfusion and the early stages of septic shock.

In response to these findings, the clinical team debates the immediate need for invasive mechanical ventilation to correct the severe gas exchange abnormalities and relieve the respiratory muscles. Discussions also include the potential modification of his antibiotic regimen in consultation with the infectious disease specialist, pending the final blood culture results. The team recognizes the critical need for hemodynamic support, considering the initiation of vasopressors to address Mr. Johnson's hypotension. This situation requires vigilant monitoring and prompt adjustments to the treatment plan to prevent further deterioration and stabilize Mr. Johnson's condition.

Section 5

The healthcare team decides to proceed with invasive mechanical ventilation due to Mr. Johnson's worsening respiratory status. After intubation and initiation of mechanical ventilation, an immediate reassessment reveals stabilization in his respiratory rate, now at 16 breaths per minute, and an improvement in SpO2 to 92%. Despite these improvements, Mr. Johnson's blood pressure remains low at 90/56 mmHg, and his heart rate continues at 112 beats per minute. The need for hemodynamic support becomes evident, prompting the administration of norepinephrine to address the persistent hypotension.

As the team collaborates with the infectious disease specialist, it is decided to broaden Mr. Johnson's antibiotic coverage while awaiting culture results. A combination of vancomycin and piperacillin-tazobactam is initiated to target potential resistant organisms, considering the elevated white blood cell count and the risk of sepsis. Close monitoring of Mr. Johnson's response to these interventions is critical, with serial lactate measurements planned to assess perfusion and response to therapy.

Despite these efforts, a new challenge emerges as Mr. Johnson develops acute kidney injury, indicated by a rise in serum creatinine to 2.1 mg/dL from a baseline of 1.0 mg/dL. Urine output has decreased to less than 20 mL/hour, suggesting oliguria. This complication raises concern for potential multi-organ dysfunction and necessitates a further adjustment in the treatment plan. The nephrology team is consulted to evaluate the need for renal support and to optimize fluid management. The interdisciplinary team remains vigilant, recognizing the complexity of Mr. Johnson's condition and the critical need for coordinated care to prevent further deterioration.